Agoracom Blog Home

Posts Tagged ‘CSE’

Else $BABY.ca $BABYF Launches a Nationwide Brand Campaign in the U.S.: “In an Else World” $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 7:22 AM on Thursday, November 12th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced the launch of its first National U.S. brand campaign, ‘In an Else World .’
  • Ahead of its nationwide retail launch in 380 stores across the U.S., the company has enlisted the global creative agency, Allenby Concept House and the award-winning Animation Director, Sivan Kidron to conceptualize the creative for the campaign
  • Click here to  view the full version video

VANCOUVER, BC , Nov. 12, 2020 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY.V) (OTC-QB: BABYF) ( Frankfurt : 0YL.F) (“Else” or the “Company”) the plant-based baby, toddler and children’s nutrition company , today announced the launch of its first National U.S. brand campaign, ‘In an Else World .’

Ahead of its nationwide retail launch in 380 stores across the U.S., the company has enlisted the global creative agency, Allenby Concept House and the award-winning Animation Director, Sivan Kidron to conceptualize the creative for the campaign. Click here to  view the full version video.

The campaign includes an interactive Instagram Live series with featured appearances from leading pediatricians, registered nurses and dietitians, including Kacie Barnes , MCN, RDN, LD and Hillary Sadler , MSN, RCN-OB, IBCLC as well as celebrity mom, Hilaria Baldwin . Tune into the series on Tuesdays at 1:00 p.m. EST , by following @elsenutrition on Instagram.

The campaign aims to spread Else Nutrition’s mission of providing real, plant-based and no-compromise nutrition alternatives for parents to feed their child, building the kind of world where families can choose nutrition that aligns with their values and needs.

Coming to life through bold and colorful animation, Else Nutrition welcomes all consumers to an ‘Else World’ where whole-food, plant-based nutrition is everywhere, especially in the baby aisle.  Focusing on the brand’s core values of providing natural products that are better for the baby, the parent and the planet, Else is excited to showcase its sustainable and cleaner offerings, including its first, breakthrough product – ‘Else Plant-Based Complete Nutrition for Toddlers’.

“We’re excited to launch our first, national marketing campaign. We’re inviting all parents to join us in building an Else World : the kind of world our babies and children deserve: with cleaner, less processed, whole-food plant-based nutrition, and a healthier planet. Since launching Else Nutrition we’ve seen how our ground-breaking plant-based nutrition has helped families around the U.S. provide their children with proper nutrition,” said Mrs. Hamutal Yitzhak , CEO and Co-Founder of Else Nutrition. “We believe that babies and children should have the same clean label, plant-based nutrition choices as their parents do, without compromise. We are excited to have the opportunity to increase awareness with consumers that will bring these ideals and values to life for millions of families across North America .”

“Together with the inspiring Else Nutrition team, we have created a world in which alternative possibilities are always available and all you need to do is to be open  to them,” said Sivan Kidron, Animation Director. “The animation plays on this idea, showing us what is behind and beyond what we currently see, while continuously opening our minds to new and exciting alternatives and innovations.”

Follow @elsenutrition on Instagram. Join an Else World on Instagram and Facebook by following #ElseWorld.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

For more information, visit: elsenutrition.com or @elsenutrition on Facebook and Instagram.

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Loop Insights $MTRX.ca $RACMF to Launch UKLIPZ, First Ever Artificial Intelligence Verified Mobile Video Review Platform for Consumers and Brands $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:13 AM on Thursday, November 12th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the January 2021 launch of UKLIPZ
  • The first ever platform that enables consumers to create verified reviews using mobile video that can also be used, purchased or analyzed by brands and retailers to drive further engagement and sales
  • UKLIPZ was acquired by Loop on September 16th, 2019
  • Loop Insights CEO, Rob Anson, stated, “The long-awaited integration of UKLIPZ into our product stack is a very important milestone for Loop due to the significant strength it adds to our offering and the disruption it creates in the massive but problematic consumer review industry. We have already begun discussions with key brands and retailers and believe UKLIPZ will become both a very significant new stream of revenue and valuable asset in 2021.”

VANCOUVER, British Columbia, Nov. 12, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space is pleased to announce the January 2021 launch of UKLIPZ, the first ever platform that enables consumers to create verified reviews using mobile video that can also be used, purchased or analyzed by brands and retailers to drive further engagement and sales. UKLIPZ was acquired by Loop on September 16th, 2019 .

Loop Insights CEO, Rob Anson, stated, “The long-awaited integration of UKLIPZ into our product stack is a very important milestone for Loop due to the significant strength it adds to our offering and the disruption it creates in the massive but problematic consumer review industry. We have already begun discussions with key brands and retailers and believe UKLIPZ will become both a very significant new stream of revenue and valuable asset in 2021.”

THE PROBLEM – AMAZON AND WALMART FLOODED WITH FAKE REVIEWS DURING PANDEMIC

On October 19th, Bloomberg News reported that approximately 42% of 720 million Amazon reviews assessed by monitoring service Fakespot were unreliable, while approximately 36% of Walmart.com reviews assessed by Fakespot during the same period were fake.

THE SOLUTION – LOOP ACCESS TO TRANSACTIONS AUTHENTICATES CONSUMER REVIEWS

Customer reviews have become the cornerstone of every retail and e-commerce platform because 63% of customers are more likely to purchase from a site with user reviews. In 2019, YELP, the business review site, generated over $USD 1.01 Billion in revenue.

Loop has the ability to access 100% of all transactions both in-store and online, where our technology is deployed through either our IoT device Fobi (i.e., TELUS IoT marketplace customers) or our POS integration partners such as Vend, Shopify, and others.

As a result of this transparency, Loop can validate the authenticity of consumer reviews posted on the UKLIPZ platform. This unique ability provides a strong differentiator regarding any other deemed competitive platforms in the marketplace today.

UKLIPZ is set to disrupt the social, video marketing, and review industry, which is expected to reach $52B USD by 2023, according to Statista.

THE ADVANTAGES FOR BRANDS AND CONSUMERS

For brands, UKLIPZ will simplify the process of sourcing, creating, curating, and licensing authentic customer reviews. Furthermore, UKLIPZ offers brands real-time measurable attribution for hyper-local, regional, and national campaign performance metrics. Moreover, it can provide brands with digital focus groups and product testing campaigns, as well as target and seek out reviews from specific audiences based on demographics and interests.

Current review sites and solutions simply cannot provide this level of detail and engagement.

For consumers, UKLIPZ provides them with an ability to create a verified and direct connection with their favourite brands, which opens the door to generating income from creating further video reviews, participating in product testing, and other opportunities.

For consumers, curated content created by them is arguably the most powerful influencer of brand and product sales today. The UKLIPZ platform enables consumers to create authenticated video reviews, create a verified and direct connections with their favourite brands, and potentially turn them into income-generating brand influencers and ambassadors.

MONETIZATION AND FURTHER STRENGTHENING THE LOOP INSIGHTS OFFERING

The launch of the UKLIPZ platform is another important strategic move by providing our partners and customers with another immediate complimentary plug-in to expand and significantly strengthen the current Loop solution offering.

Revenues from UKLIPZ will be generated through multiple streams as follows:

  • Monthly SaaS fees from Brands and Retailers;
  • Transaction fees when a consumer purchases through the platform
  • Brands purchasing use of consumer video reviews;
  • Sponsored ads

User-generated content drives a 74% increase in click-through rates, while 45% of marketers surveyed by Forrester agree that user-generated content improves social media advertising and influencer campaigns. UKLIPZ provides brands with an easy way to incentivize and empower customers, employees, and influencers to engage and promote the products they love. This is especially true given that word-of-mouth advertising remains the richest path to authenticity, new customers, and ROI.

As a result of the Covid -19 pandemic, the global retail market faces its largest challenge in decades. According to Forrester.com , the latest forecast on global retail sales deficit will mass more than $2.1 Trillion in 2020. The strong shining light is the emergence and rise in mobile commerce. With an expected increase of 25.6%, Mobile is the growth engine of digital commerce. As a result of Covid-19, consumers have been forced to educate themselves and to embrace mobile and e-commerce, and rely on online retailers for their purchase. As a result of the rapid digital transformation, consumer authentic and trusted reviews have never been more important to consumers, brands, and retailers. The company is confident that it will greatly benefit from strong revenue growth from the built-in mobile commerce within UKLIPZ.

AMAZON PARTNER DESIGNATION OPENS UP DOORS TO GLOBAL FORTUNE 500 RETAILERS AND BRANDS

Rob Anson added , “Every brand on the planet is looking for two things, direct access to their consumer and to understand their behaviour across all channels including e-commerce, mobile commerce, and in-store commerce. UKLIPZ will deliver the sought-after data intelligence through our Artificial Intelligence platform and facilitate direct brand to consumer access and connection.”

This press release is available on the Loop Insights Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/LoopInsights

Watch more here:
https://vimeo.com/359399719

About Uklipz
Loop’s vision for Uklipz is to build a global brand as the premier, trusted source of authentic, user-generated reviews using technology that allows anyone with a smartphone to create, post, and monetize video reviews. Uklipz revolutionizes digital brand and marketing assets by offering a direct and highly personalized feedback loop. With Uklipz, customers are literally at your fingertips. Brands gain an ability to engage directly with consumers in the heat of the moment, both in-store and online.

About Loop Insights
Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network.

For more information, please contact:
Loop Insights Inc.LOOP Website : www.loopinsights.ai
Rob Anson, CEOFacebook: @ LoopInsights
T : +1 877-754-5336 Ext. 4Twitter: @ LoopInsights
E : [email protected]LinkedIn: @ LoopInsights

Forward-Looking Statements/Information:

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

#Cannabis #Pharmaceuticals Market: Rise in investments by #pharma companies in #CBD to drive the market – SPONSOR: Avicanna $AVCN.ca $AVCNF $CARA $GWPH $TBP.ca $CRBP $PCLO.ca

Posted by AGORACOM-JC at 5:04 PM on Wednesday, November 11th, 2020

SPONSOR: Avicanna (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) is a Canadian vertically-integrated biopharmaceutical company developing and commercializing various cannabinoid-based products for the global market place. When we say vertically integrated, we mean it.  Avicanna has 4 fully operating divisions to address the entire market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Avicanna offers you exposure to the entire vertical. Learn More.

http://www.smallcapepicenter.com/Avicana%20square%20logo.jpg
  • Cannabis-based products or the medical marijuana has orchestrated new avenues in the pharmaceuticals industry
  • Pharma companies, small and big, have plowed investments in cannabidiol (CBD), particularly
  • The inroad made by CBD and CBD-based products is unarguably daunting, riding on the wave of staggered legalization of marijuana
  • The game-changing potential that cannabis has made pharma companies nurse new aspirations by setting their sights in the cannabis pharmaceuticals market

Unsurprisingly, some pharma companies for instance, Insys Therapeutics, put robust opposition to legalization of marijuana. The regulatory status on the CBD is markedly unclear and lack worldwide consensus, for instance, differs from state to state in the U.S., and from nation to nation. Nonetheless, over the years there is a clear surge in interest of pharma companies in medical marijuana, given the medical conditions where cannabis hold incredible potential.

FDA-approved CBD-based drugs will stridently see an increase, expanding the horizon in the CBD market. One of the most recalcitrant diseases CBD-based products in cannabis pharmaceuticals market hold potential, as body of preclinical studies have reiterated, is Dravet syndrome and Lennox-Gastaut syndrome (LGS).

A new study on the cannabis pharmaceuticals market scrutinizes the investment potential of some of the aforementioned trends and the ways in which those will shape the growth dynamics during 2020 – 2030.

Cannabis Pharmaceuticals Market: Key Trends

The shape of the cannabis pharmaceuticals market is expected to be molded by the changing dynamic of the regulatory landscape. A large part of negative public perception of cannabis products has been associated with the recreational use of TSH, a key psychoactive element of cannabis. However, as things have begun to change, the global medicinal industry will intensify its efforts in harnessing therapeutic benefits of cannabis.

The cannabis pharmaceutical industry will see new vistas opening up from expanding array of studies that will provide scientific backing of CBD. This is particularly in relation to the safety and uncontested claims of safety. Further, as regulators will treat different categories of cannabis-based product differently and suitably, the risk benefit profile of cannabis pharmaceuticals will become clearer. The scientific rigor for evidence-based medicine will expand the potential of the market and pave way for research in purified cannabidiol.

Two areas where the industry nurses tall hopes in the cannabis pharmaceuticals market are in reducing opioid epidemic, and in managing some of the hard-to-treat conditions such as some cancers. Stakeholders also appreciate the potential of medical cannabis for aesthetic and medical dermatology.

Cannabis Pharmaceuticals Market: Competitive Analysis and Key Developments

The cannabis pharmaceuticals market has seen numerous big shot companies testing new waters in medical marijuana, and making strategic moves to this end. Research units of a few top pharma companies have made moves toward commercializing cannabinoids for medical use. A recent example is research being made by Avicanna for Johnson & Johnson, and by Vapium for Grenco Science.

Another company, notably a spin-off of Abbott Laboratories, AbbVie Inc. has upped its cannabis-related patents. These developments will undoubtedly strengthen the pipeline of cannabis-related drugs, unlocking new prospects in the cannabis pharmaceuticals market. In the course of time, more start-up companies will ramp up their efforts in patenting Cannabis-based tablets and products.

Another behemoth that is making giant stride in the cannabis pharmaceuticals market is Teva Pharmaceuticals. The company recently announced formally that it has entered into distribution deal with cannabis company Canndoc.

Cannabis Pharmaceuticals Market: Regional Assessment

North America has seemed to garner incredible revenue potential among all key geographies in the cannabis pharmaceutical market over the past several years. The groundswell of interest in medical marijuana is circumscribed by favorable regulations in some quarters, notably in parts of the U.S. Intense discussion among industry stakeholders about the taxing and labelling of cannabis-based medicinal products will cement the potential of the regional market. They are keen on increasing the profitability of marijuana-based products. Another promising region is Europe, expanding on the back of rise in investments by pharma companies in CBD.

Read More: https://www.biospace.com/article/cannabis-pharmaceuticals-market-rise-in-investments-by-pharma-companies-in-cbd-to-drive-the-market-/

Innocan $INNO.ca Enters Into Distribution Agreement to Sell its #CBD Derma Cosmetic Products in Germany $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 4:10 PM on Wednesday, November 11th, 2020
Innocan-Blog
  • Entered into a distribution agreement with iAmHealth Distribution UG, a CBD products provider in Germany to sell the Company’s SHIR Beauty and Relief & Go product lines in Germany.
  • iAmHealth will distribute Innocan’s unique cosmetic CBD products in Germany on a non-exclusive basis. The Agreement defines the ordering and delivery mechanisms for the products and the marketing cooperation between the parties.
  • The parties intend to carry out the Agreement immediately following the completion of all registration and regulatory requirements in Germany.

Herzliya, Israel and Calgary, Alberta–(November 11, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that its wholly owned subsidiary, Innocan Pharma Ltd. (“Innocan Israel“) has entered into a distribution agreement dated 4, 2020 (the “Agreement“) with iAmHealth Distribution UG (“iAmHealth“), a CBD products provider in Germany to sell the Company’s SHIR Beauty and Relief & Go product lines in Germany.

Under the terms of the Agreement, iAmHealth will distribute Innocan’s unique cosmetic CBD products in Germany on a non-exclusive basis. The Agreement defines the ordering and delivery mechanisms for the products and the marketing cooperation between the parties. The parties intend to carry out the Agreement immediately following the completion of all registration and regulatory requirements in Germany.

Nina Wlodarczyk, iAmHealth’s Managing Director commented: “Our iAmHealth team comes from the medical industry with research based on science. As cannabidiol (“CBD”) became more available and gained popularity in Germany, we wanted to make our contribution and create a place for all of our existing customers, as well as people who are looking for new products they can trust, and with a high level of efficacy. We believe Innocan, as a pharmaceutical oriented company, is the perfect fit to complement the range of our existing products that we offer to the German consumer.”

Iris Bincovich, Innocan’s Founder and CEO, commented: “We are excited to start our product distribution in Germany. This is one of several distribution agreements that we have signed in Europe. I believe iAmHealth will provide a premier distribution channel for our SHIR and Relief & Go product lines.”

iAmHealth GmbH

iAmHealth Distribution UG, a subsidiary of iAmHealth GmbH (www.iam.health), is a collaborative group of multidisciplinary professionals from various sectors focusing on therapeutic formulations, including clinical trials, product development and manufacturing. iAmHealth has built a network of trustworthy Medical, R&D, Financial and Legal partners to supply and provide valuable expertise and extensive knowledge. iAmHealth is dedicated to the online distribution of various cosmetics and lifestyle products, utilizing an advanced, Artificial Intelligence driven e-commerce platform, enabling complete efficacy and security to a wide range of end consumers. iAmHealth strives to offer the very best cosmetics, natural products and CBD, which are highly trustworthy and proven, at reasonable prices, which support and increase the well-being of its customers.

About Innocan

The Company, through its wholly owned subsidiary, Innocan Israel, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining CBD with other products. Innocan Israel and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Corona Virus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. The Company plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. The Company is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

$KABN.ca North America Announces Hiring of Mackie Research Capital Corporation for Capital Markets Services $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 9:28 AM on Wednesday, November 11th, 2020
kabn-square-new

  • Announced that it has engaged Mackie Research Capital Corporation as a financial and capital markets advisor to the Company
  • Service agreement includes providing advice and assistance in connection with defining strategic and financial objectives, making initial contacts with potential institutional and strategic investors, maintaining a regular dialogue with the Company in regards to corporate development, strategic growth objectives as well as general market sentiment, assist in maintaining an orderly and liquid market in the Company’s shares and increasing market awareness of KABN North America.

TORONTO, ON / ACCESSWIRE / November 11, 2020 / KABN Systems NA Holdings Corp. (CSE:KABN) (the “Company” or “KABN North America” or “KABN NA“), a Canadian Fintech company that specializes in continuous online identity verification, management and monetization in Canada and the U.S., is pleased to announce that it has engaged Mackie Research Capital Corporation (“Mackie“) as a financial and capital markets advisor to the Company.

The service agreement includes providing advice and assistance in connection with defining strategic and financial objectives, making initial contacts with potential institutional and strategic investors, maintaining a regular dialogue with the Company in regards to corporate development, strategic growth objectives as well as general market sentiment, assist in maintaining an orderly and liquid market in the Company’s shares and increasing market awareness of KABN North America.

KABN North America has agreed to retain Mackie as its Canadian financial advisor for a term of twelve (12) months ending November 10, 2021, and the arrangement may be extended by mutual agreement.

“We are very excited to be working with the Mackie team to extend our reach in the Canadian public marketplace,” said David Lucatch, CEO of KABN NA. “We believe that this relationship will create additional value for the Company and our stakeholders.”

As part of the compensation for its services, Mackie will receive a monthly fee of $6,500 for its trading advisory services for a minimum of 6 months with extension by mutual agreement and a financial advisory fee of $75,000 payable in common shares in the capital of the Company at a deemed price equal to $0.15 per common share. In addition, The Company will grant 1,500,000 common share purchase warrants (the “Broker Warrants“) to Mackie Research. Each Broker Warrant will entitle the holder thereof to purchase one common share in the capital of the Company at an exercise price of $0.20 at any time up to 24 months following the date of issuance.

The issuance including, but not limited to, the price of the common shares and warrants is subject to the rules of the Canadian Securities Exchange and remains subject to applicable regulatory approvals.

About Mackie Research Capital Corporation

Macie Research Capital Corporation is one of Canada’s largest independent full servicce investment firms, and proudly traces its roots back to 1921. Mackie Research is privately owned by many of its 300 employees. As a fully integrated national investment dealer, Mackie Research offers a full complement of capital markets and wealth managment services to private clients, institutions and growth companies.

About KABN North America – www.kabnnaholdco.com

KABN Systems NA Holdings Corp. through its wholly owned subsidiary KABN Systems North America Inc. focuses on the verification, management and monetization of digital identity, empowering users to control and benefit from its use of their online identity. KABN NA’s propriety technology suite includes 4 key products:

Liquid Avatar allows users to create high quality digital icons representing their online personas. These icons, in conjunction with KABN ID, allows users to manage and control their Digital Identity and to use Liquid Avatars to share public and permission based private data when they want and with whom they want. www.liquidavatar.com

KABN ID is an Always On, biometric and blockchain based digital identity validation and verification platform allowing users to continuously and confidently prove themselves throughout the online community.

KABN Card is a Visa approved prepaid card program allowing users to manage both digital and fiat currencies and earn cashback and other loyalty incentives. www.kabncard.com

KABN KASH is a cashback, loyalty and engagement program that powers the KABN NA’s revenue ecosystem.

KABN NA provides its products and services at no cost to consumers and generates revenues through permission-based partner programs. www.kabnkash.com

For more information, please visit www.kabnnaholdco.com or www.kabnsystemsna.com

For further information, please contact:

David Lucatch
647-725-7742 Ext. 701
[email protected]

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities under the KABN Financing in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. The forward-looking information and forward-looking statements contained herein may include, but is not limited to, information concerning the ability of the Company to generate revenues, roll out new programs and to successfully achieve business objectives, including to accelerate the Company’s development, customer acquisition and business platform, and expectations for other economic, business, and/or competitive factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, the Company has made certain assumptions. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws; compliance with extensive government regulation. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws.

Red Light Holland $TRIP.ca to Acquire Wholesale Distribution Company in the Netherlands Providing Access to over 1,000 Retail Outlets in Multiple EU Countries $SHRM.ca $RVV.ca

Posted by AGORACOM at 9:28 AM on Tuesday, November 10th, 2020
Red-Light-Holland-Square

  • Announced it has entered into a non-binding letter of intent to acquire SR Wholesale B.V. one of the Netherlands’ premiere distributors for quality Truffles, CBD products, cannabis seeds, Smartshop items, Headshop products, Growshop goods and Cannabis Bake House edibles
  • SR Wholesale has established a distribution network of over 300 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

Toronto, Ontario–(November 10, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC: TRUFF) (“Red Light Holland” or the “Company“), is pleased to announce it has entered into a non-binding letter of intent to acquire SR Wholesale B.V. (“SR Wholesale“), one of the Netherlands’ premiere distributors for quality Truffles, CBD products, cannabis seeds, Smartshop items, Headshop products, Growshop goods and Cannabis Bake House edibles. SR Wholesale has established a distribution network of over 300 companies that sell their products across Europe, including working with sub-distributors which provide products to over 1,000 shops in countries like the Netherlands, Germany, Spain, Czech, Greece, UK, France, and Portugal.

“This is a huge step forward for Red Light Holland, potentially rapidly expanding the distribution of our iMicrodose Packs to an expected 150-200 Smartshops. As well, the potential acquisition of SR Wholesale enables Red Light Holland to own one of the Netherlands’ top wholesale companies, in the sector,” said Todd Shapiro, CEO and Director of Red Light Holland. “While there is a due diligence process ahead, including understanding all the legalities of SR Wholesale’s extensive business, we at Red Light Holland are extremely excited by the potential to significantly expand our footprint and our revenues in the Netherlands, plus a plethora of other countries in the EU via the distribution network SR Wholesale has with over 1,000 retail shops.”

“So far working with Hans Derix and Todd Shapiro has been an amazing experience,” said Shai Ramashai, CEO of SR Wholesale. “My team and I have built an amazing wholesale and distribution business, with prompt service, where over 1,000 retail shops, all over Europe, have relied on us for quality products, as fast as you they can make the order! We pride ourselves on our dedicated customer service team, and we are confident that, if the final acquisition comes to fruition, Red Light Holland, with my assistance, will continue to grow, what we have worked so hard in doing since its successful inception in 2017.”

Separately, Red Light Holland is pleased to report that SR Wholesale has also entered into a definitive purchase agreement to buy the entire crop of Red Light Holland’s expected 100,000 grams of psilocybe Galindoi, psilocybe Mexicana and psilocybe Tampanensis Truffles, from the Company’s first official harvest.

About SR-Wholesale B.V.

SR Wholesale B.V. is a Dutch company based in Schijndel, Netherlands, specialized in the selection, distribution and export of Products such as Truffles, CBD products, cannabis seeds, Smartshop items, Headshop products, Growshop goods and Cannabis Bake House muffins, cookies and cakes. SR Wholesale has been operating successfully in the exceptionally competitive sales market for more than 4 years, in multiple European countries reaching over 1,000 retail shops.

About Red Light Holland Corp.

The Company is an Ontario-based corporation positioning itself to engage in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on the Company:
Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Forward-Looking Statements

PlantX $VEGA.ca Partners with House Plant Shop to Launch New U.S. Indoor Plant Store on PlantX.com $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 8:45 AM on Tuesday, November 10th, 2020
PlantX | LinkedIn
  • Announced its partnership with House Plant Shop who will assist PlantX with launching its U.S. plant vertical
  • The Company will also feature House Plant Shop products on its new U.S. e-commerce platform
  • Partnership will allow PlantX, the digital face of the plant-based community and one-stop-shop for everything plant-based, to offer an extensive plant selection to its U.S. consumer base

VANCOUVER, BC , Nov. 10, 2020 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) is pleased to announce its partnership with House Plant Shop who will assist PlantX with launching its U.S. plant vertical. The Company will also feature House Plant Shop products on its new U.S. e-commerce platform.

The partnership will allow PlantX, the digital face of the plant-based community and one-stop-shop for everything plant-based, to offer an extensive plant selection to its U.S. consumer base. House Plant Shop will make available all of its products from its California greenhouse to PlantX customers throughout the U.S. Over 200 variants of plant-related products will be immediately available to U.S. consumers including an extensive array of plants, pots, gardening tools, accessories and decorations with plans to eventually reach over 500 products. As House Plant Shop adds more products to its lineup, they will be added to the PlantX marketplace.

Since 2017, House Plant Shop has provided an accessible and affordable solution for everyday customers looking to purchase houseplants online. Its small operation started in a house and quickly grew into a well-equipped greenhouse in Southern California . Today, House Plant Shop supplies several large e-commerce companies, with PlantX being the latest to source its products for the Company’s online platform and its eventual brick and mortar location in San Diego . PlantX believes that the indoor plant market will be an important growth segment for the Company.

“We love to see our newly launched U.S. e-commerce platform expand like its predecessor PlantX.ca,” said Julia Frank , PlantX CEO. “We firmly believe that our U.S. plant vertical will generate massive revenue and growth.”

“House Plant Shop is excited to announce its partnership with PlantX, an innovative company focused on incorporating plants into everyday life,” said Andy Burde , House Plant Shop co-founder. “Together, both companies will continue to foster the plant community and encourage plant production over unnatural materials.”

PlantX will continue to expand its verticals on both its Canadian and U.S. e-commerce platforms, with plans to globally expand its platforms and offerings in its promotion of plant-based health, wellness, lifestyles, and education.

The Company website is http://investor.PlantX.com/ .

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the Company’s partnership with House Plant Shop, House Plant Shop products becoming available on the Company’s e-commerce platform, the expected growth in House Plant Shop’s product line, the Company’s new brick and mortar location in San Diego , the Company’s expectations regarding the growth of the indoor plant market and the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

SOURCE PlantX Life Inc.

Hollister Biosciences $HOLL.ca $HSTRF Launches Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 8:15 AM on Tuesday, November 10th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1
  • Announced the launch of its direct to consumer cannabis delivery platform, Dreamy Delivery
  • Company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California, to ensure a seamless customer experience in early Q4 of 2020
  • Company hopes to launch Dreamy in Sacramento and the Central Coast of California by late Q4 of 2020 with the ultimate goal of delivering Cannabis statewide

VANCOUVER, BC , Nov. 10, 2020 – Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) (FRANKFURT: HOB) (the ” Company “, ” Hollister Cannabis Co. ” or ” Hollister “) a diversified cannabis branding company with products in over 280 dispensaries throughout California , and over 80 dispensaries throughout Arizona , is pleased to announce the launch of its direct to consumer cannabis delivery platform, Dreamy Delivery (” Dreamy ” or the ” Platform “).

The company soft launched Dreamy Delivery to friends and family in the San Francisco Bay Area of Northern California ( “Bay Area “), to ensure a seamless customer experience in early Q4 of 2020. The Company has expanded the Platform, with Dreamy now successfully delivering to legal cannabis consumers in the Bay Area. The Company hopes to launch Dreamy in Sacramento and the Central Coast of California by late Q4 of 2020 with the ultimate goal of delivering Cannabis statewide.

Carl Saling , CEO of Hollister , shared: “This is a major first step in our quest to be the dominant direct to consumer platform delivering cannabis to the entire state of California .”

Website: www.dreamydelivery.com

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products. Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com .

VIDEO – Loop $MTRX.ca $RACMF Delivers First Ever End To End COVID-19 Venue Bubble – Major Milestone For The Global Venue Industry $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 5:24 PM on Monday, November 9th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Loop Insights (MTRX:TSXV)(RACMF:OTCQB) was already a leading provider of contactless solutions and artificial intelligence (“AI”) to the brick and mortar space prior to the arrival of COVID-19.  

Over the last few months Loop has adapted its contactless platform to also provide contact tracing and real-time testing to large venues and businesses.  More than just lip service, Loop has already announced significant partnerships and news with the likes of: 

TELUS  

Loop was recently accepted into the TELUS IoT Marketplace for national sales and marketing to TELUS business Customers

Andrew Turner, TELUS VP Strategic Operations,  

“By partnering with innovative and leading IoT development companies, such as Loop, we’re ensuring that our customers have access to some of the most advanced IoT business solutions in the world.” 

AMAZON 

On October 29th, the Company announced that Amazon Web Services (AWS) and Loop Insights would be hosting an interactive webinar to showcase the Company ‘ s Venue Tracing Solution to a global audience of businesses to learn about the technical, security, privacy, and commercial aspects of Loop ‘ s Venue Tracing Platform.  

 The invitees were from industries including but not limited to:  

  • Airlines
  • Venue Owners
  • Sports & Entertainment
  • Telecom
  •  Government 

How did the webinar go?  On October 30th Loop announced Early Response To Amazon Web Services And Loop Insights Showcase Of Loop Venue Tracing Solution To Global Audience Indicates Great Success

The presentation ended at approximately 1:15 PM EST, and by 8:00 PM EST Loop had received over 100 direct inquiries from enterprise-level attendees spanning many different industries and countries. Loop Insights anticipates many more direct inquiries to be received in the coming days.

Today, the Company announced the first ever end-to-end COVID-19 Venue Bubble for an upcoming NCAA Basketball Tournament in Florida.

Watch this great interview with Loop Insights CEO, Rob Anson.

VIDEO – Hollister $HOLL.ca $HSTRF Reports Record Q3 Revenues With $12.5M From 360+ Dispensaries In California and Arizona $CRON $GTBIF $INDS $META.ca $FAF.ca $WEED.ca

Posted by AGORACOM-JC at 4:23 PM on Monday, November 9th, 2020
https://prnewswire2-a.akamaihd.net/p/1893751/sp/189375100/thumbnail/entry_id/1_dd2snc3b/def_height/400/def_width/400/version/100011/type/1

Hollister Biosciences (HOLL:CSE) is a multi-state operator with multiple, high-quality products that are now carried in 280 of California’s 600 dispensaries, where it also claims California’s #1 hash infused pre-roll “HashBone” … and if that is all they had you would have the makings of a great small cap cannabis company. 

But there is more …. way more. 

Venom Extracts is their 100% owned subsidiary that is absolutely dominating the state of Arizona.  More than just lip service:

  • Venom just surpassed $30,000,000 (MILLION) in revenue YEAR TO DATE
  • Venom Extracts is one of Arizona’s premier extract brands 
  • One of the state’s largest producers of medical cannabis distillate and related products
  • The products are award winning
  • ….. And it is run by the absolute coolest guy in small cap Cannabis – Jake Cohen  

THE NUMBERS SAY IT ALL 

1.  RECORD Q3 REVENUE          $12.5M 

2.  CRAZY REVENUE GROWTH    5,200%

3.  RECORD EBITDA                 $1.265M (vs a loss of $362,000) In case you’re wondering if this was a fluke quarter, this is what Q2 looked like: 

  • RECORD REVENUE of $US 8.47M, compared to $200,000 last year and representing an increase of 4,170%
  • NET INCOME of $300,000, compared to a loss of $2.1M, representing a turnaround of $2.4M over last year 

HOLLISTER HEADED TOWARDS $50,000,000 REVENUE? 

If you’re paying attention, HOLL is achieving enormous growth both year over year and sequentially.  If we extrapolate the latest Q3 numbers, Hollister is on a $50,000,000 annualized revenue run rate assuming no further growth. 

But there is more. 

The State of Arizona just approved recreational cannabis in Arizona.  This is a potential windfall for Venom given the fact its brand, reputation and dispensary penetration from its award winning medical cannabis is about as good as it gets.  How good is Hollister now? 

How good does it get? 

Watch this incredible interview with Venom Extracts Founder Jake Cohen, the coolest exec in small cap cannabis because he delivers incredible results with sweat, swagger and great swag to boot.  

Watch this interview or listen by Podcast on AppleGoogleSpotify or your favourite podcaster.